- Home
- BRKR
BRKR
Bruker Corporation
as 12-20-2024 4:00pm EST
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.
| Founded: | 1991 | Country: | United States |
| Employees: | N/A | City: | BILLERICA |
| Market Cap: | 9.1B | IPO Year: | 2000 |
| Target Price: | $75.67 | AVG Volume (30 days): | 1.5M |
| Analyst Decision: | Buy | Number of Analysts: | 13 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 2.06 | EPS Growth: | -4.69 |
| 52 Week Low/High: | $48.07 - $94.86 | Next Earning Date: | 02-11-2025 |
| Revenue: | $3,241,300,000 | Revenue Growth: | 15.00% |
| Revenue Growth (this year): | 15.26% | Revenue Growth (next year): | 7.64% |
Stock Insider Trading Activity of Bruker Corporation (BRKR)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| PACKER RICHARD A | BRKR | Director | Dec 2 '24 | Sell | $57.82 | 3,350 | $193,682.60 | 80,904 | |
| LAUKIEN FRANK H | BRKR | PRESIDENT & CEO | Nov 18 '24 | Buy | $50.67 | 100,000 | $5,014,068.82 | 38,409,429 |
Latest Bruker Corporation News
BRKR Breaking Stock News: Dive into BRKR Ticker-Specific Updates for Smart Investing
Business Wire
2 days ago
Bruker Announces 1.2 GHz NMR Spectrometer at Swiss High-field NMR Facility
MT Newswires
3 days ago
Guggenheim Initiates Coverage on Bruker With Buy Rating, $72 Price Target
Argus Research
4 days ago
BRKR: Lowering target price to $46.00
Argus Research
11 days ago
BRKR: Raising target price to $48.00
MT Newswires
12 days ago
UBS Downgrades Bruker to Neutral From Buy, Cuts Price Target to $66 From $102
Simply Wall St.
13 days ago
3 US Growth Stocks With High Insider Ownership To Watch
Zacks
17 days ago
Why Is Bruker (BRKR) Up 0.9% Since Last Earnings Report?
MT Newswires
17 days ago
Goldman Sachs Upgrades Bruker to Neutral From Sell, Price Target is $60
Compare BRKR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BRKR Bruker Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.